| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44028560 | HTLV-1 | ENSG00000197081.16 | protein_coding | IGF2R | No | No | 3482 | P11717 |
| TVIS44007834 | HTLV-1 | ENSG00000197081.16 | protein_coding | IGF2R | No | No | 3482 | P11717 |
| TVIS44033036 | HTLV-1 | ENSG00000197081.16 | protein_coding | IGF2R | No | No | 3482 | P11717 |
| TVIS44039094 | HTLV-1 | ENSG00000197081.16 | protein_coding | IGF2R | No | No | 3482 | P11717 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | IGF2R |
|---|---|
| DrugBank ID | DB16708 |
| Drug Name | Cipaglucosidase alfa |
| Target ID | BE0003623 |
| UniProt ID | P11717 |
| Regulation Type | ligand |
| PubMed IDs | 30843882; 37184753 |
| Citations | Xu S, Lun Y, Frascella M, Garcia A, Soska R, Nair A, Ponery AS, Schilling A, Feng J, Tuske S, Valle MCD, Martina JA, Ralston E, Gotschall R, Valenzano KJ, Puertollano R, Do HV, Raben N, Khanna R: Improved efficacy of a next-generation ERT in murine Pompe disease. JCI Insight. 2019 Mar 7;4(5). pii: 125358. doi: 10.1172/jci.insight.125358. eCollection 2019 Mar 7.@@Blair HA: Cipaglucosidase Alfa: First Approval. Drugs. 2023 Jun;83(8):739-745. doi: 10.1007/s40265-023-01886-5. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
